【其他高分选 065】

BC

PMID: 39267061

IF:10.6

Preparation and effects of functionalized liposomes targeting breast cancer tumors using chemotherapy, phototherapy, and immunotherapy

PMID:39265497

IF:10.7

Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors

PMID:39276011

IF:27.4

Microfluidic Platform for Generating and Releasing Patient-Derived Cancer Organoids with Diverse Shapes: Insight into Shape-Dependent Tumor Growth

PMID:39272206

IF:10.6

Transformable self-delivered supramolecular nanomaterials combined with anti-PD-1 antibodies alleviate tumor immunosuppression to treat breast cancer with bone metastasis

PMID:39271787

IF:81.1

Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance

PMID:39277592

IF:14.7

Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance

PMID:39286776

IF:10.7

The interaction of innate immune and adaptive immune system

PMID:39285252

IF:27.7

The complexity of immune evasion mechanisms throughout the metastatic cascade

PMID:39285187

IF:14.7

Lattice expansion in ruthenium nanozymes improves catalytic activity and electro-responsiveness for boosting cancer therapy

PMID:39285160

IF:13

Targeting SNRNP200-induced splicing dysregulation offers an immunotherapy opportunity for glycolytic triple-negative breast cancer

PMID:39284128

IF:42.1

Insights and Limitations of the Study on Temporary Interruption of Endocrine Therapy and Assisted Reproductive Technology Use in Breast Cancer Survivors

PMID:39284124

IF:42.1

Advancing Fertility Preservation in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy: Societal and Psychological Implications

PMID:39287044

IF:15.8

Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer

PMID:39287113

IF:14.3

LncRNA FAISL Inhibits Calpain 2-Mediated Proteolysis of FAK to Promote Progression and Metastasis of Triple Negative Breast Cancer

PMID:39287520

IF:12.1

Breast Cancers Detected during a Decade of Screening with Digital Breast Tomosynthesis: Comparison with Digital Mammography

PMID:39287527

IF:12.1

Implications of Digital Breast Tomosynthesis in Breast Cancer Screening: Reducing Advanced Breast Cancers

CRC

PMID:39265577

IF:45.5

TEX264 drives selective autophagy of DNA lesions to promote DNA repair and cell survival

PMID:39266533

IF:14.7

SHANK3 depletion leads to ERK signalling overdose and cell death in KRAS-mutant cancers

PMID:39267084

IF:11.4

Recruitment of USP10 by GCS1 to deubiquitinate GRP78 promotes the progression of colorectal cancer via alleviating endoplasmic reticulum stress

PMID:39269307

IF:10

Epigenome reprogramming through H3K27 and H3K4 trimethylation as a resistance mechanism to DNA methylation inhibition in BRAFV600E-mutated colorectal cancer

PMID:39272040

IF:27.7

Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer

PMID:39271253

IF:56.7

Optimizing Rectal Cancer Treatment: A Path Towards Personalization

PMID:39276942

IF:25.7

Where do non-invasive colorectal cancer tools 'FIT' alongside colonoscopy in the surveillance of high-risk patients?

PMID:39278355

IF:10.5

Endoplasmic reticulum-targeted biomimetic nanoparticles induce apoptosis and ferroptosis by regulating endoplasmic reticulum function in colon cancer

PMID:39285586

IF:20.1

Local TSH/TSHR signaling promotes CD8(+) T cell exhaustion and immune evasion in colorectal carcinoma

PMID:39284974

IF:31.7

Systematic prioritization of functional variants and effector genes underlying colorectal cancer risk

PMID:39287948

IF:10.5

Financial Hardship Among Patients With Early-Stage Colorectal Cancer

PMID: 39288075

IF:12.5

CD24-Targeted NIR-II Fluorescence Imaging Enables Early Detection of Colorectal Neoplasia

GC

PMID: 39272149

IF:27.7

Exosomal miR-4745-5p/3911 from N2-polarized tumor-associated neutrophils promotes gastric cancer metastasis by regulating SLIT2

PMID: 39272146

IF:10.6

Circ_0001947 encapsulated by small extracellular vesicles promotes gastric cancer progression and anti-PD-1 resistance by modulating CD8(+) T cell exhaustion

HCC

PMID:39266052

IF:23

Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular carcinoma

PMID:39267048

IF:10.6

ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway

PMID:39270063

IF:12.9

Disparity landscapes of viral-induced structural variations in hepatocellular carcinoma: Mechanistic characterization and functional implications

PMID:39286779

IF:10.7

A novel small molecule ZYZ384 targeting SMYD3 for hepatocellular carcinoma via reducing H3K4 trimethylation of the Rac1 promoter

PMID:39285180

IF:14.7

Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models

PMID: 39284185

IF:19.6

Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B : A Multinational Study for the Development and External Validation of a New Prognostic Model

PMID: 39284186

IF:19.6

Revised REACH-B Model for Hepatocellular Carcinoma Risk Prediction in Patients With Chronic Hepatitis B

LC

PMID:39266564

IF:14.7

Context-aware single-cell multiomics approach identifies cell-type-specific lung cancer susceptibility genes

PMID:39266533

IF:14.7

SHANK3 depletion leads to ERK signalling overdose and cell death in KRAS-mutant cancers

PMID:39265598

IF:38.7

Plinabulin, a microtubule destabilising agent, in non-small-cell lung cancer: lessons from the DUBLIN-3 trial

PMID:39265528

IF:11.1

Overcoming drug-resistant tumors with selection gene drives